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Although it is appreciated that canonical signal-transduction pathways represent dominant
modes of regulation embedded in larger interaction networks, relatively little has been done to
quantify pathway cross-talk in such networks. Through quantitative measurements that
systematically canvas an array of stimulation and molecular perturbation conditions, together
with computational modeling and analysis, we have elucidated cross-talk mechanisms in the
platelet-derived growth factor (PDGF) receptor signaling network, in which phosphoinositide
3-kinase (PI3K) and Ras/extracellular signal-regulated kinase (Erk) pathways are prominently
activated. We show that, while PI3K signaling is insulated from cross-talk, PI3K enhances
Erk activation at points both upstream and downstream of Ras. The magnitudes of these effects
depend strongly on the stimulation conditions, subject to saturation effects in the respective
pathwaysandnegativefeedbackloops.Motivatedbythosedynamics,akineticmodelofthenetwork
was formulated and used to precisely quantify the relative contributions of PI3K-dependent and
-independent modes of Ras/Erk activation.
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Introduction
Signal transduction is traditionally characterized in terms of
intracellular pathways, which govern outcomes such as cell
proliferation, survival, migration, and differentiation. Cross-
talk interactions, which couple distinct pathways, are recog-
nized for their importance in cell regulation yet remain poorly
deﬁned because of their complex nature (Hunter, 2000). They
allow information ﬂow and regulation to be distributed across
multiple pathways, and perturbations targeting speciﬁc
signaling molecules might therefore have unexpected effects
(Bray, 1990). Here, we describe the systematic and quantita-
tivecharacterizationofcross-talkbetweentwomajorsignaling
pathways, phosphoinositide 3-kinase (PI3K) and Ras/extra-
cellular signal-regulated kinase (Erk), which play prominent
roles in signaling networks accessed by many cell surface
receptors. Signaling mediated by platelet-derived growth
factor (PDGF) receptors, members of the receptor tyrosine
kinase class of signal transducers (Claesson-Welsh, 1994;
Schlessinger, 2000), is relevant to wound healing, develop-
ment, and cancer (Heldin and Westermark, 1999) and is
distinguished by potent activation of type IA PI3Ks, which
control a host of cellular responses through the production of
speciﬁc lipid second messengers (Vanhaesebroeck et al, 2001;
Engelman et al, 2006; Hawkins et al, 2006). PDGF receptors
also enhance signaling through Ras proteins by promoting
Ras guanine nucleotide exchange factor (Ras-GEF) activity
and hence an increase in GTP-bound Ras; in this state,
Ras activates the canonical Raf/mitogen-activated protein
kinase (MAPK) or Erk kinase (MEK)/Erk cascade. Erk
isoforms are both master integrators of upstream signals and
master controllers of transcription factors and other effectors
(Kolch, 2000).
Although cross-talk between the PI3K and Ras/Erk path-
ways has been studied extensively, a deﬁnitive pattern of
regulation has not yet emerged, because the two pathways
apparently affect each other in various ways and in a context-
dependent manner. Despite striking evidence that PI3Ks bind
to and are activated by Ras-GTP (Rodriguez-Viciana et al,
1994), the effects of blocking Ras signaling on growth factor-
stimulated PI3K activation range from partial inhibition
(Rodriguez-Viciana et al, 1994; Klinghoffer et al, 1996) to very
little or no inhibition (Klippel et al, 1996; Kaur et al, 2006).
Numerous reports have also implicated PI3K in the activation
or regulation of Ras/Erk signaling, but again with disparate
conclusions being drawn (discussed in Duckworth and
Cantley, 1997). Although PI3K inhibitors apparently abrogate
Erk activation but not Ras-GTP loading in certain contexts
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1997; King et al, 1997), other reports indicate a role for PI3K
upstream of Ras (Hu et al, 1995; DePaolo et al, 1996; Hawes
et al, 1996; Wennstro ¨m and Downward, 1999).
Through a kinetic analysis of PI3K and Ras/Erk signaling in
the PDGF receptor system, complemented by quantitative
modeling (Tyson et al, 2003; Ma’ayan et al, 2005; Kholodenko,
2006), we ﬁnd that PI3K signaling affects Erk activation both
upstream and downstream of Ras, and that Ras and PI3K
account for most, if not all, of the pathways from PDGF
receptors to Erk. The magnitudes of the Ras- and PI3K-
dependent effects are shown to depend strongly on the
stimulation conditions, in ways that are readily explained
based on the saturability of the respective pathways and
negative feedback mechanisms. Interestingly, cross-talk from
theRas/ErkpathwaytoPI3Kisshowntobefarlesssigniﬁcant,
an observation that we speculate is tied to the ability of PDGF
receptors to directly and potently activate PI3K signaling.
Through modeling and computation, the magnitudes of PI3K-
dependent cross-talk mechanisms are quantiﬁed, and predic-
tions are generated to inform further reﬁnement of those
mechanisms.
Results
Ras and PI3K make independent contributions to
Erk signaling, whereas PI3K is effectively
insulated from cross-talk
To systematically evaluate cross-talk between the PI3K and
Ras/Erk pathways, Erk phosphorylation and PI3K-dependent
Akt phosphorylation in PDGF-stimulated NIH 3T3 ﬁbroblasts
weremeasured by quantitativeimmunoblotting foran arrayof
126 experimental conditions, sampling different combinations
of ligand dose, stimulation time, and molecular manipulation
(Figures 1 and 2). Considering biological replicates and
parallel determination of total Erk and Akt levels, this data
set comprises 2772 total measurements. We have conﬁrmed
on multiple occasions that the immunoblot imaging system
used produces a linear response as a function of epitope
loaded, over a sufﬁciently broad dynamic range (unpublished
results).
The results reveal that when either Ras or PI3K is inhibited,
by the expression of dominant-negative (S17N) H-Ras or
incubation with LY294002 compound, respectively, PDGF-
stimulated Erk phosphorylation is partially inhibited (Figure
1A–C). Expression of S17N H-Ras sequesters Ras-GEFs
and thus affects activation of all Ras isoforms, and we
conﬁrmed previously that it prevents PDGF-stimulated Ras-
GTP loading in our cells (Kaur et al, 2006); we also conﬁrmed
that the control compound LY303511, which is pharmacologi-
cally similar to LY294002 except that it does not inhibit
PI3K (Knight et al, 2006; Gharbi et al, 2007), does not affect
Erk phosphorylation signiﬁcantly (Supplementary Figure S1).
The degree of Erk inhibition depends strongly on both
stimulation dose and time; no single combination of these
conditions is indicative of the relative roles of Ras and PI3K in
activating Erk. At short stimulation times, PI3K inhibition
signiﬁcantly affects Erk activation at low but not high PDGF
concentrations, in accord with a previous study (Duckworth
and Cantley, 1997); however, even at saturating PDGF
concentrations, Erk phosphorylation in PI3K-inhibited cells
is less sustained, with signiﬁcantly lower values than the
control at later stimulation times. The effects of Ras inhibition
are similar, except that Erk phosphorylation is less sensitive to
PDGF concentration and shows a lower initial rate at higher
PDGF doses (compare Figure 1B and C). As we will show,
these subtle differences in the kinetics between PI3K- and
Ras-inhibited cells are indicative of distinct pathways inte-
grated by Erk.
Expression of constitutively active (G12V) H-Ras yields not
only an elevated level of Erk phosphorylation prior to
stimulation but also a somewhat reduced responsiveness to
PDGF (Figure 1D), consistent with high constitutive expres-
sion of MAPK phosphatase (MKP) as reported previously
(Kaur et al, 2006); indeed, the basal expression of MKP-1 is
roughly 17-fold higher in G12V Ras-expressing cells (results
not shown). Thus, Erk signaling in these cells is the net result
of both higher phosphorylation and higher dephosphorylation
rates. Erk phosphorylation is mediated by both G12V H-Ras
and PDGF-responsive signaling, which presumably includes
activation of endogenous Ras isoforms and pathways that
depend on PI3K.
By comparison, the PI3K pathway is not signiﬁcantly
activated through cross-talk from Ras. Neither expression of
dominant-negative Ras nor application of the MEK inhibitor
PD098059 has a signiﬁcant effect on Akt phosphorylation
(Figure 2A–C); the latter treatment is expected to enhance
Ras-GTP loading by relieving feedback desensitization of the
Ras-GEF mSos (Klarlund et al, 1995; Langlois et al, 1995;
Waters et al, 1995), but the only effect of the drug is a slight
reduction of the peak Akt phosphorylation. Expression of
constitutively active Ras results in a higher basal Akt
phosphorylation level in unstimulated cells but does not
grossly affect PDGF-stimulated Akt phosphorylation. When
Akt phosphorylation is far from saturation, the PDGF-
stimulated response is incremented by the basal level,
suggesting an approximately additive relationship; there is
also evidence that the saturated Akt phosphorylation response
is more sustained in G12V Ras-expressing cells (Figure 2D).
Therefore, whereas inhibiting activation of endogenous Ras
did not signiﬁcantly affect PDGF-stimulated PI3K/Akt signal-
ing in this study, high levels of Ras-GTP cooperate with PDGF
receptors in a subtle way to activate this pathway (Jime ´nez
et al, 2002; Kaur et al, 2006).
These results suggest two possible Erk activation mechan-
isms, or combinations thereof: Ras and PI3K promote Erk
signaling independently, or PI3K lies upstream of Ras in the
same pathway, in which case at least one additional
pathway would be responsible for the residual Erk phosphor-
ylation seen when either Ras or PI3K is inhibited. In
each of three independent experiments, simultaneous inhibi-
tion of Ras and PI3K almost completely abolished PDGF-
stimulated Erk phosphorylation, indicating that Ras and PI3K
are responsible for all of the major pathways from PDGF
receptors to Erk, and at least one mode of PI3K-dependent
cross-talk to Erk operates in parallel with Ras (Figure 3).
Incidentally, this result also provides further conﬁrmation
that Ras function is effectively blocked in our S17N Ras-
expressing cells.
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upstream and downstream of Ras
Having established a role for PI3K-dependent signaling to Erk
in parallel with Ras, we sought to determine whether or not
PI3K also partially contributes to the PDGF receptor-mediated
activation of Ras. Using a coupled enzymatic assay (Scheele
et al, 1995; Kaur et al, 2006), we measured the kinetics of
PDGF-stimulated Ras-GTP loading for selected conditions
(Figure 4). In each of three independent experiments,
Figure 1 Systematic analysis of PDGF-stimulated Erk phosphorylation kinetics. (A) Immunoblots, representative of ﬁve or six independent experiments, used to
quantifyrelativeamountsofphosphorylatedErk(p-Erk1/2)andtotalErk(t-Erk1).NIH3T3ﬁbroblastsweremodulatedbyretroviralinductionofdominant-negative(S17N)
orconstitutivelyactive(G12V)H-RasexpressionorincubationwithinhibitorsofPI3K(100mMLY294002)orMEK(50mMPD098059).Therespectivecontrolsareempty
pBM-puro vector or 0.2% DMSO. Lysates were prepared from cells that were unstimulated or stimulated with PDGF-BB for 5, 15, 30, 60, or 120min. (B–E)
QuantiﬁcationofErkphosphorylation,normalizedasdescribedunderMaterialsandmethods,comparingeitherS17NRasexpression(B;n¼6),PI3Kinhibition(C;n¼5),
G12VRasexpression(D;n¼6),orMEKinhibition(E;n¼5)withtheirrespectivecontrols.Valuesarereportedasmean±s.e.m.,andcomparisonstocontrolin(B,C)are
by Student’s t-test: *Po0.05; **Po0.01. Source data is available for this ﬁgure at www.nature.com/msb.
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loading at a low PDGF concentration (50pM), whereas Ras-
GTP loading kinetics were minimally affected at 1nM PDGF.
Interestingly, the plateau level of Ras-GTP in PI3K-inhibited
cells was similar to that of control cells, even at the lower dose
of PDGF.
As alluded to in the previous section, Ras-GTP loading is
affected by a known negative feedback loop that destabilizes
Ras-GEF recruitment, and accordingly, incubation with
PD098059 yields a higher Ras-GTP level (Figure 4). The
feedback loop might also explain the effect of PI3K inhibition
seen at lower PDGF concentrations. Erk phosphorylation is
dramatically reduced under those conditions (Figure 1C), and
thus the feedback regulation might be relieved. The net effect
of reduced but stable Ras-GEF recruitment would be a lower
initial rate and more sustained level of Ras-GTP loading.
Figure 2 Systematic analysis of PDGF-stimulated Akt phosphorylation kinetics. (A) Representative immunoblots used to quantify relative amounts of phosphorylated
Akt (p-Akt) and total Akt (t-Akt) for the same set of experimental conditions as in Figure 1. (B–E) Quantiﬁcation of Erk phosphorylation, normalized as described under
Materialsandmethods,comparingeitherS17NRasexpression(B;n¼6),MEKinhibition(C;n¼5),G12VRasexpression(D;n¼6),orPI3Kinhibition(E;n¼5)withtheir
respective controls. Values are reported as mean±s.e.m. Source data is available for this ﬁgure at www.nature.com/msb.
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integrated Erk phosphorylation response
In addition to feedback regulation of Ras-GEF, we also
characterized the upregulation of MKP expression induced
by Erk and other MAPKs (Brondello et al, 1997; Bhalla et al,
2002; Plows et al, 2002) (Figure 5A and B). MKP-1 expression
is upregulated B3-fold in response to 1nM PDGF, after a lag
time of approximately 15min. At 30pM PDGF, which elicits
roughly half-maximal Erk phosphorylation (Figure 1B and C),
MKP-1 expression increases only slightly, suggestive of a
signaling threshold for triggering the feedback loop. A similar
MKP-1 response is observed when either Ras or PI3K is
inhibited, with a partial reduction in the fold induction
(Figure 5B); this outcome can be attributed at least in part to
the diminished Erk phosphorylation response, integrated over
time, when either of the two major pathways is disrupted. As
expected, inhibition of MEK/Erk or c-Jun N-terminal kinase
(JNK) (but not of p38; results not shown) signiﬁcantly reduces
the induction of MKP-1 expression, and simultaneous inhibi-
tion of MEK and JNK blocks MKP-1 upregulation completely
(Figure 5C).
Parsing the magnitudes of PI3K-dependent
cross-talk interactions in the PDGF receptor
signaling network
Synthesizing the data assembled, a conceptual model of the
PDGF receptor signaling network is now clear (Figure 6). Yet,
the unique dose–response and kinetic information in the data
set allow for a more quantitative description through
mathematical modeling and analysis. The relatively coarse
granularity of our model, described in detail in the Supple-
mentary information, reﬂects a careful balance between the
level of molecular detail included and both the uncertainty of
thosedetailsandtheabilitytospecifymodelparameters.Inthe
context of the model, the magnitudes of the Ras- and PI3K-
dependent inputs converging on MEK/Erk determine the
Figure 3 Rasand PI3K account forall of the major PDGF-stimulated pathways
that converge on Erk. NIH 3T3 ﬁbroblasts were infected with retrovirus produced
from empty vector or vector with S17N H-Ras, pretreated with either DMSO
control or LY294002, then stimulated with PDGF-BB (dose and time indicated).
AlthoughinhibitionofRasorPI3KpartiallyblocksErkphosphorylation,consistent
with Figure 1B and C, blocking both Ras and PI3K abolishes Erk
phosphorylation. The results are representative of three independent experi-
ments.
Figure 4 Quantitative Ras-GTP loading measurements: characterization of
PI3K-dependent cross-talk and Erk-dependent feedback regulation. NIH 3T3
ﬁbroblasts were stimulated with PDGF-BB as indicated; pretreatments were
control (0.2% DMSO), LY294002 (100mM), or PD098059 (50mM). Ras-GTP
levels were measured using a quantitative enzymatic assay and normalized as
described under Materials and methods; values are reported as mean±s.e.m.
(n¼3). Source data is available for this ﬁgure at www.nature.com/msb.
Figure 5 Delayed onset and threshold for MKP-1 upregulation, a known
negative feedback loop in the Erk pathway. (A) Immunoblots of MKP-1 levels in
control, PI3K-inhibited, or S17N H-Ras-expressing cells that were unstimulated
or stimulated with PDGF-BB for 5, 15, 30, 60, or 120min; each blot is
representative of two or three independent experiments. (B) Quantiﬁcation of
MKP-1expression,witheithertotalErk1ortotalproteinastheloadingcontroland
normalized as described under Materials and methods. Values are reported as
mean±s.e.m. (n¼3 for DMSO and LY294002; n¼2 for control vector and S17N
Ras). (C) MEK/Erk and JNK pathways contribute to feedback upregulation of
MKP-1. PDGF stimulation was 1nM for 60min. MEK or/and JNK were inhibited
by incubation with 50mM PD098059 (PD) and 25mM SP600125 (SP),
respectively. The DMSO concentration was 0.25% in all cases. The blot is
representative of two independent experiments. Source data is available for this
ﬁgure at www.nature.com/msb.
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and also the degree to which the response adapts, and
conversely, the observed dynamics can be used to quantify
the magnitudes of the inputs.
A total of 34 unspeciﬁed parameter values were estimated
using a Monte Carlo-based algorithm that directly and globally
compares the model output to the experimental data (Supple-
mentary information); thus, an ensemble of 10000 parameter
sets that ﬁt the data almost equally well was assembled. This
approach embraces the inherent ‘sloppiness’ of kinetic
models, which prohibits the reliable identiﬁcation of precise
parametervaluesyet allowsfor predictionsbased oncollective
ﬁts to data (Gutenkunst et al, 2007). The model output is
expressed as an ensemble average (Brown and Sethna, 2003;
Violin et al, 2008) and compared with the corresponding data
(Figure 7). The remaining data used to constrain the algorithm
indicate the degree of saturation in the MEK/Erk pathway
(Supplementary Figure S2). Taken together, the data force the
model to reconcile time- and PDGF dose-dependent featuresof
the network observed under the various experimental condi-
tions tested, including subtle differences between the two
control experiments (DMSO vehicle only versus empty pBM-
puro vector). Considering the global constraints imposed by
the data and the necessarily simpliﬁed nature of the kinetic
model, itis ourassessmentthat the modelperforms quitewell;
however,onefeaturethatitwasnotabletoreconcilewellisthe
sensitivity of the Erk phosphorylation response in S17N Ras-
expressing cells stimulated with the lower doses of PDGF
(Figure 7; bottom row, second plot from left). We speculate
that the apparent sensitivity of the response, relative to the
model output, is diminished bycell variability. It is known that
variability in the cells’ sensitivity to stimulation (the EC50 of
the dose–response curve) produces a ﬂatter dose–response
curve for the population (Altan-Bonnet and Germain, 2005).
The model also does not capture the transient nature of the
S17N Ras/30pM PDGF curve, suggesting that ligand depletion
or other negative feedback effects might need to be character-
ized and accounted for in future reﬁnements of the model.
Indeed, the transient nature of the Akt phosphorylation
response at low PDGF concentrations (Figure 2) provides
additional evidence for such effects affecting PI3K-dependent
signaling.
Figure 6 Conceptual model of the PDGF receptor signaling network. Cross-
talk interactions from PI3K lipid products (30 PIs) affect Ras-speciﬁc GEF (e.g.
Grb2–Sos complex) recruitment and activation of MEK kinases, which might or
might not be the same as those activated by Ras. It is recognized that those
cross-talkeffectsmightentailmultiplesteps,andthatamorereﬁnedmodelwould
account for the effect of JNK activation on the MKP negative feedback loop.
Figure 7 Computational model and algorithm for direct comparison to experimental data. A quantitative kinetic model of the network was formulated, and a Monte
Carloschemewasusedtocollectanensembleofparametersetsthatﬁtourdatasetwell(Supplementaryinformation).Thesolidcurvesrepresentensemblemeans,and
the dashed curves are mean±s.d. (n¼10000). The data values used to constrain the model (symbols) are also shown (see also Supplementary Figure S3). PDGF
concentrations are: red, 1nM; green, 300pM; blue, 100pM; gray, 50pM; black, 30pM.
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many parameters tend to be pegged at arbitrarily high values,
suggesting ways to simplify the model without a signiﬁcant
change in output. For example, the algorithm consistently
picked parameter sets in which the enzymes operate far from
saturation.ThisobservationfacilitatesouranalysisofRas-and
PI3K-dependent MEK phosphorylation, in which we examine
the catalytic efﬁciencyof each phosphorylation step relative to
that of the opposing dephosphorylation reaction (Figure 8A).
The results reveal a consistent ratio of PI3K- and Ras-
dependent contributions, as indicated by points clustered
around a diagonal line, with the Ras-dependent pathway
tending to be more potent under maximal PDGF stimulation.
To further quantify these pathways, we formulated a single
number, the MEK activation comparator (MAC), which
compares their capacities to generate dually phosphorylated
MEK (ratio of PI3K-dependent/Ras-dependent; see Supple-
mentary information). Over the parameter set ensemble, the
median MAC value is 0.22, with quartile values of 0.17 and
0.30; that is, the PI3K-dependent MEK activation pathway is
predictedtobeintrinsicallylesspotentthantheRas-dependent
pathway under maximal PDGF stimulation. Importantly, the
MAC quantiﬁes these inputs in a way that uncouples them
fromnegativefeedbackeffects.AsshowninFigure7,feedback
desensitization attenuates the maximum stimulation of Ras-
GTP by roughly two-thirds. Adjusting the MAC to account for
this reduction, which presumably affects both Ras-dependent
MEK phosphorylation steps equally, yields a median ratio
of 1.6 (quartile values of 1.2 and 2.1); that is, Ras-GEF
desensitization renders the PI3K-dependent pathway more
important. This is consistent with the observation that
PI3K inhibition affects Erk phosphorylation somewhat more
dramatically than inhibition of Ras-GTP loading.
Upstream of Ras, a similar analysis was performed for PI3K-
dependent and -independent modes of Ras-GEF recruitment,
which are characterized by speciﬁc model parameters
(Figure 8B). Taken together, these modes determine the
saturability of Ras-GTP loading with respect to PDGF dose.
Although most of the parameter sets in the ensemble included
a signiﬁcant PI3K-dependent contribution, a small fraction of
them ignored the PI3K-dependent mode, which we attribute to
the subtlety of the data constraining it (the effect of PI3K
inhibition on Ras-GTP accumulation). Deﬁning the GEF
recruitment comparator (GRC) as the ratio of PI3K-depen-
dent/PI3K-independent modes at low PDGF concentrations
(see Supplementary information), the median GRC value for
the ensemble is 1.4, with quartile values of 0.7 and 2.0. This
analysis suggests that the twoRasactivation modes are almost
equally important.
Model predictions and potential for model
reﬁnement
We have shown how data-driven analysis of a kinetic model
can be used to quantify inputs to signaling pathways.
Another use of this approach is to generate hypothetical
predictions with an eye toward future experiments. Here,
we focus on the PI3K-dependent cross-talk impinging
upstream and downstream of Ras (Figure 9). Although both
mechanisms are blocked by PI3K inhibition, the model
ensemble predicts unique kinetic signatures that might be
expected if either mechanism were silenced selectively. At
lower PDGF concentrations, it is predicted that blocking
either mechanism would yield Erk phosphorylation levels
that are intermediate between control and PI3K-inhibited
conditions, but the key discriminator is the Erk phosphoryla-
tion kinetics observed with a high PDGF dose; there, if the
cross-talk mechanism upstream of Ras is blocked, the
kinetics are predicted to be similar to control conditions,
whereas if the mechanism downstream of Ras is blocked, the
kinetics are predicted to be similar to the PI3K-inhibited case
(Figure 9). The basis for this result stems from the saturability
of Ras-GEF recruitment, wherein high PDGF concentrations
stimulate maximal Ras-GTP loading even in the absence of
PI3K signaling.
Figure 8 Quantitative analysis of PI3K-dependent cross-talk to Ras/Erk. (A) Quantiﬁcation of Ras- and PI3K-dependent MEK phosphorylation pathways. For each
parameterset describedunder Figure 7, the quantityCxij isdeﬁned asthe maximum catalyticefﬁciency ofpathway i (i¼1, Rasdependent; i¼2,PI3K dependent) toward
site j on MEK divided by the catalytic efﬁciency of the corresponding phosphatase reaction (Supplementary information). On the dashed line, the two pathways are
equally potent by this measure. (B) Quantiﬁcation of the PI3K-independent and -dependent modes of Ras-GEF recruitment. These are characterized by the model
parameters KGR and KGP, respectively, plotted here for each parameter set in the ensemble. The factor of 123 is a scaling factor (Supplementary information); when
KGP¼KGR/123 (dashed line), the two modes contribute equally to Ras-GEF recruitment in the limit of low PDGF concentration.
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A unique data set was collected to systematically characterize
multiple cross-talk interactions between the PI3K and Ras/Erk
pathways and regulatory feedback loops in the PDGF receptor
signaling network. PI3K is strongly activated and plays a
prominent role in this system, and Ras- and PI3K-dependent
pathways converge as distinct inputs to Erk activation that we
have quantiﬁed experimentally and through computational
modeling. At lower PDGF concentrations, Erk activation
qualitatively follows AND logic, with both inputs required
for a robust response, whereas it follows OR logic at higher
PDGF concentrations, wherein either pathway is sufﬁcient.
The basis for these observations lies in the saturability of the
pathways. Half-maximal PDGF receptor phosphorylation is
elicited by B0.5–1nM PDGF-BB (Park et al, 2003), concentra-
tionsthatyieldmaximalactivationofPI3KandRasinourcells;
downstream of Ras, we also ﬁnd partial saturation of MEK
or Erk. The magnitudes of the inputs to the Erk pathway
also affect adaptation of the response imposed by negative
feedback regulation.
In contrast, cross-talk from the Ras/Erk pathway to PI3K is
far less signiﬁcant, which might be considered surprising in
light of the interaction between Ras-GTP and PI3K catalytic
subunits. Apparently, Ras does not appreciably complement
the already tight binding between PDGF receptors and PI3K
(Kazlauskas and Cooper, 1990), whereas Ras might play a
more signiﬁcant role in conjunction with receptors/adaptors
that bind PI3K regulatory subunit with lower afﬁnity (Kaur
et al, 2006).
To advance this line of inquiry, the PI3K-dependent
intermediates that execute the cross-talk to Erk will need to
be better and more quantitatively characterized. One candi-
date pathway is the phosphorylation of Raf-1 on Ser
338, which
has been implicated in Raf-1 activation. Phosphorylation of
Raf-1onSer
338iscatalyzedbyisoformsofp21-activatedkinase
(Pak), which can be activated downstream of PI3K and either
Rac or Cdc42 (Chaudhary et al, 2000; Sun et al, 2000). Raf-1
mutants that cannot bind Ras-GTP can be activated in cells
by co-expression of Pak3 and constitutively active Cdc42,
suggesting a Ras-independent pathway (Sun et al, 2000),
whereasotherevidencesuggestsaroleforRasintheactivation
ofRaf-1byRac/Cdc42andPak(Lietal,2001;Zangetal,2002).
Consistent with this literature, we found that Raf-1 phosphor-
ylation on Ser
338 stronglydepends on both PI3Kand Rasin our
cells (results not shown); from the standpoint of cross-talk
from PI3K to Erk, this ﬁnding is inconclusive, because it does
not account for the Ras-independent pathway in our cells.
Other aspects of Raf-1 regulation might account for the
pathway, as there is ample evidence that Ser
338 phosphoryla-
tion is not a strong correlate of Raf-1 activity (Sun et al, 2000;
Chiloeches et al, 2001; Oehrl et al, 2003; Beeser et al, 2005);
regulation of other Raf isoforms and other putative MEK
kinases, such as Pak (Beeser et al, 2005; Park et al, 2007) and
3-phosphoinositide-dependent protein kinase 1 (Sato et al,
2004), might also be considered. It is also worth noting that
such PI3K-dependent modes of Erk activation could mask a
subtle negative regulation of the Erk pathway, through Akt for
example (Zimmermann and Moelling, 1999); however, over-
expression of Akt-1 does not affect PDGF-stimulated Erk
phosphorylation in our cells, despite a two-fold increase in
phosphorylated Akt (results not shown). Finally, although at
least one important mode of PI3K-dependent cross-talk to Erk
is Ras independent, PI3K lipid products apparently contribute
upstream of Ras as well, perhaps through direct recruitment
of Ras-speciﬁc GEF activity or through mediators such as
centaurin-a1 (Hayashi et al, 2006).
If such mechanisms are to be tested, mathematical model
predictions provide kinetic signatures that could help validate
the point of action of a particular pathway from PI3K to Erk.
For example, if a particular kinase contributing to the Ras-
independent Erk activation pathway were blocked, the model
predicts that the time courses of Erk phosphorylation at both
low and high PDGF concentrations would be perturbed
relative to control (Figure 9). Furthermore, the extent of
perturbation relative to complete PI3K inhibition, especially at
high PDGF concentrations, reveals the degree to which the
kinase is playing a major role in the pathway. Such an analysis
would require quantitative measurements of the type pre-
sented here. Importantly, the extent of Erk inhibition in the
dominant-negative Ras background would lend further evi-
dence and opportunity for model validation. In turn, char-
acterization of cross-talk mechanisms along these lines allows
both conceptual and quantitative models to be reﬁned. The
data set generated here, together with new data, will be
instrumental in iteratively testing more detailed models of the
PDGF receptor signaling network.
Anotherissuethatneedstobeconfrontedisthegeneralityof
signal-transduction networks across receptor and cell types.
Certainly, major disparities in the regulation of signaling in
Figure 9 Model predictions based on ensemble averaging. Predictions are
based on hypothetical interventions by which the PI3K-dependent cross-talk
upstream or downstream of Ras are selectively blocked (Supplementary
information), which can be compared with control and PI3K-inhibited (all cross-
talk blocked) conditions. Solid curves represent ensemble means, and dashed
curves are mean±s.d. (n¼10000). PDGF concentrations are: red, 1nM;
black, 30pM.
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should be expected. Indeed, it is instructive to compare the
PDGF receptor network to the proposed regulatory structure
ascribed to epidermal growth factor (EGF) receptor, which has
been the subject of numerous quantitative modeling efforts
(Wiley et al, 2003). Recent experimental and modeling work
has provided compelling evidence that EGF receptor signaling
throughPI3KandErkarecoupledprimarilythroughregulation
of Gab1 (Kiyatkin et al, 2006). According to that model,
phosphorylated Gab1 recruits PI3K, and Gab1 responds to 30
phosphoinositides, constituting a positive feedback loop;
Gab1 also aids in the activation of Ras. Further, Gab1 and
therefore PI3K are subject to a negative feedback loop
mediated by Erk. The evidence suggests that the inability of
EGF receptors to interact directly with PI3K demands the
utilization of Gab1 and thus dictates the important features of
that network. In contrast, PDGF receptors activate PI3K
directly and strongly, perhaps explaining why PI3K is not
subject to regulation by Erk in our cells; other evidence
suggests that Gab1 is prominently utilized to recruit PI3K in
response to EGF, but not PDGF, in the same cell background
(Zhang et al, 2002). Clearly, control at the network level is
highly context dependent, and more quantitative approaches
will be needed to unravel the mechanisms that distinguish
particular signaling systems.
Materials and methods
Reagents
All tissue culture reagents were from Invitrogen (Carlsbad, CA).
Human recombinant PDGF-BB was from Peprotech (Rocky Hill, NJ).
Antibodies against Ras (Y13-259, agarose conjugated), Akt-1/2 N
terminus, Erk-1 C terminus, and MKP-1 were from Santa Cruz
Biotechnology (Santa Cruz, CA). Phospho-speciﬁc antibodies against
Akt pSer
473, Erk pThr
202/pTyr
204, and Raf-1 pSer
338 were from Cell
Signaling Technology (Beverly, MA). Pharmacological inhibitors were
from Calbiochem (San Diego, CA); where applicable, cells were pre-
incubated with the inhibitor for 30–60min prior to PDGF stimulation.
Unless otherwise noted, all other reagents were from Sigma-Aldrich
(St Louis, MO).
Plasmids, retroviral infection, and cell culture
TheretroviralvectorsbearingS17NandG12VH-Ras,clonedintopBM-
IRES-Puro, and their introduction into the ecotropic fNX packaging
cell line by the calcium phosphate precipitation method, were
describedpreviously(Kauretal,2006).NIH3T3ﬁbroblasts(American
TypeCultureCollection,Manassas,VA)wereculturedat371C,5% CO2
in Dulbecco’s modiﬁed Eagle’s medium supplemented with 10% fetal
bovine serum, 2mM L-glutamine, and the antibiotics penicillin and
streptomycin. Where applicable, NIH 3T3 cells were serially infected
with retrovirus bearing empty vector, S17N H-Ras, or G12V H-Ras and
selected using puromycin prior to each experiment, as described
previously (Kaur et al, 2006).
Lysate preparation and biochemical assays
Cellswereserum-starved for 4h prior to stimulation. Detergentlysates
were prepared for quantitative immunoblotting, and immunoblots
were performed using enhanced chemiluminescence, as described
previously (Park et al, 2003). Blots comparing lysates prepared on the
sameday,representingeitherdifferentinhibitortreatmentsordifferent
cell variants and respective control conditions, were performed in
parallel and exposed at the same time. The Bio-Rad Fluor S-Max
system, which gives a linear responsewith respect to light output, was
used, and band intensity was quantiﬁed using local background
subtraction. Total cellular protein concentrations were determined by
Micro BCA assay (Pierce, Rockford, IL).
To determine the amounts of Ras-bound GTP (from all Ras
isoforms),elutedfromanti-Rasimmunoprecipitates(Y13-259,agarose
conjugated), the coupled nucleoside-50-diphosphate kinase/luciferase
assay (Scheele et al, 1995) was used; the determination of the sum of
GDPþGTP was achievedbyﬁrst convertingGDPtoGTP. Theseassays
were performed as described previously (Kaur et al, 2006).
Data normalization and statistical analysis
Biochemical data were ﬁrst normalized by an appropriate loading
control as stated in the ﬁgure legends. To evaluate the consistency of
relative trends across independent experiments, the data were further
normalized as follows (see also Supplementary Figure S3). Suppose
there are n experiments for which data are collected at m time points.
During each of the n experiments, the same control is run. Let Xij
denote the experimental measurement for the control in the ith
experiment at the jth time point. Often the quantity of interest Yij (for
example, the fraction of Erk or Akt in the phosphorylated state) is
related to Xij by an unknown scale factor, ai. Under ideal conditions,
the control would not vary from experiment to experiment. Therefore,
we soughtthe set of ai values that minimize the suitable errormetric F,
deﬁned as follows.
F ¼
X m
j¼1
1
  Yj
X n
i¼1
ðYij     YjÞ
2
"# 1=2
; Yij ¼ aiXij
whereY ¯ jisthemeanvaluethatresultsfortimepointj.ThefunctionFis
proportional to the mean coefﬁcient of variation for the control time
series. The minimization is subject to a constraint that eliminates the
trivial solution, ai¼0 for all i. The time course of cells stimulated with
1nM PDGF under control conditions (DMSO or empty vector) was
used to determine the normalization factors, and each factor was
applied to the remaining data collected on the same day (control
conditions with lower PDGF concentrations and either inhibitoror Ras
variant expression conditions, measured in parallel). Where appli-
cable, normalized means for control and perturbed conditions were
comparedbyStudent’s t-test, using the most conservativemodel (two-
tails, unequal variance).
Kinetic modeling and analysis
A mathematical model was constructed based on known or plausible
signaling mechanisms, with appropriate simpliﬁcations, as described
in detail in the Supplementary information. Brieﬂy, PDGF receptor
binding, dimerization, and endocytosis, and the production of 30 PI
lipids by receptor-recruited PI3K, are modeled as previously described
(Park et al, 2003;Schneiderand Haugh,2005).Activated receptorsand
30 PI lipids mediate the recruitment of Ras-GEF activity and Ras-GTP
loading; for simplicity, the roles of adaptors such as Grb2 and Shc are
implicit. Ras-GTPand 30 PI lipids independently mediatethe activation
of one or more MEK kinases, and MEK and Erk are sequentially
activated by dual phosphorylations. Activated Erk governs negative
feedback through desensitization of Ras-GEF and through upregula-
tion of MKP activity.
The model has 18 time-dependent variables and a total of 44 rate
constants or other adjustable parameters, of which 10 were assigned
ﬁxed values based on previous work. Remaining parameters were
speciﬁed using a computational scheme based on the Metropolis
algorithm, which is well suited for kinetic parameter estimation
constrainedbybiochemicaldata(BrownandSethna,2003;Violinetal,
2008). Our variation of the method, implemented in MATLAB (The
MathWorks; codes available upon request), works as follows (see
Supplementaryinformationfordetails).Startingwithinitialparameter
values, the model output is computed and aligned with the data, and
thequalityofﬁtisevaluated.Next,newvaluesarechosenaccordingto
normal distributions centered on the previous values; the width of the
distribution is a parameter of the algorithm. If speciﬁed error criteria
are met, the new parameter set is accepted and used as the nexus for
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repeated with the previous parameter set. If the starting parameter set
(determined based on a separate error minimization subroutine) is
nearly optimal, then the parameter sets generated in this manner
constitute an ensemble that ﬁt the data almost equally well. After
compiling the ensemble, the model output is recalculated for each
parameterset,andat eachtime point,an ensemble meanandstandard
deviation are calculated.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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